Beacon Pharmaceuticals (DHA:BEACONPHAR) Total Payout Ratio : 0.56 (As of May. 30, 2025)

View and export this data going back to 2010. Start your Free Trial

What is Beacon Pharmaceuticals Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Beacon Pharmaceuticals's current Total Payout Ratio is 0.56.

Beacon Pharmaceuticals Total Payout Ratio Historical Data

The historical data trend for Beacon Pharmaceuticals's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beacon Pharmaceuticals Total Payout Ratio Chart

Beacon Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Payout Ratio

Get a 7-Day Free Trial

1.00

0.15

0.07

0.40

0.73

Beacon Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Payout Ratio	Get a 7-Day Free Trial															-	-42.62	-0.02	0.01	-0.01

Competitive Comparison of Beacon Pharmaceuticals's Total Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beacon Pharmaceuticals's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beacon Pharmaceuticals's Total Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beacon Pharmaceuticals's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Beacon Pharmaceuticals's Total Payout Ratio falls into.

Save Embed

;

Save Embed

;

Beacon Pharmaceuticals Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Beacon Pharmaceuticals's Total Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	-371.06)	/	509.84
	=	0.73

Beacon Pharmaceuticals's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	3.861)	/	382.4
	=	-0.01

Beacon Pharmaceuticals Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Beacon Pharmaceuticals's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Beacon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » Total Payout Ratio

Traded in Other Exchanges

N/A

Address

9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223

Website

https://www.beaconpharma.com.bd

Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.

Beacon Pharmaceuticals Headlines

No Headlines